Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy (vol 11, pg 175, 2024)

被引：0
作者：
Yang, H.
Cong, T.
Luo, Y.
Yang, C.
Ren, J.
Li, X.
机构：
来源：
JOURNAL OF HEPATOCELLULAR CARCINOMA | 2024年 / 11卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.2147/JHC.S467902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [21] Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
    Girardi, Daniel M.
    Pacifico, Jana Priscila M.
    Guedes de Amorim, Fernanda P. L.
    dos Santos Fernandes, Gustavo
    Teixeira, Marcela C.
    Pereira, Allan A. L.
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 21
  • [22] Efficacy and Prognostic Factors of Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma
    Sun Long
    Yang Shiwei
    Fang Qing
    Liu Ping
    Zhang Rongjie
    Hu Chunfang
    Hao Yingxue
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01): : 120 - 125
  • [23] Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Teng-Kai Yang
    Ya-Fang Yu
    Chiao-Ling Tsai
    Hsing-Ju Li
    Po-Sheng Yang
    Kai-Wen Huang
    Jason Chia-Hsien Cheng
    BMC Cancer, 22
  • [24] Prognostic Prediction and Risk Stratification of Transarterial Chemoembolization Combined with Targeted Therapy and Immunotherapy for Unresectable Hepatocellular Carcinoma: A Dual-Center Study
    Kang, Wendi
    Zhao, Huafei
    Lian, Qicai
    Li, Hang
    Zhou, Xuan
    Li, Hao
    Weng, Siyuan
    Yan, Zhentao
    Yang, Zhengqiang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 2169 - 2179
  • [25] Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
    Farasati Far, Bahareh
    Rabie, Dorsa
    Hemati, Parisa
    Fooladpanjeh, Parastoo
    Faal Hamedanchi, Neda
    Broomand Lomer, Nima
    Karimi Rouzbahani, Arian
    Naimi-Jamal, Mohammad Reza
    LIVERS, 2023, 3 (01): : 121 - 160
  • [26] Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Yang, Teng-Kai
    Yu, Ya-Fang
    Tsai, Chiao-Ling
    Li, Hsing-Ju
    Yang, Po-Sheng
    Huang, Kai-Wen
    Cheng, Jason Chia-Hsien
    BMC CANCER, 2022, 22 (01)
  • [27] Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
    Nishikawa, Hiroki
    Nishijima, Norihiro
    Enomoto, Hirayuki
    Sakamoto, Azusa
    Nasu, Akihiro
    Komekado, Hideyuki
    Nishimura, Takashi
    Kita, Ryuichi
    Kimura, Toru
    Iijima, Hiroko
    Nishiguchi, Shuhei
    Osaki, Yukio
    ONCOLOGY LETTERS, 2017, 14 (02) : 1637 - 1647
  • [28] Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma
    Tazi, El Mehdi
    Essadi, Ismail
    M'rabti, Hind
    Touyar, Anass
    Errihani, Hassan P. R.
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2011, 3 (04) : 167 - 175
  • [29] Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma
    Bin X.
    Luo Z.
    Wang J.
    Zhou S.
    Computational and Mathematical Methods in Medicine, 2023, 2023
  • [30] Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
    Kroeze, Stephanie G. C.
    Fritz, Corinna
    Schaule, Jana
    Siva, Shankar
    Kahl, Klaus H.
    Sundahl, Nora
    Blanck, Oliver
    Kaul, David
    Adebahr, Sonja
    Verhoeff, Joost J. C.
    Skazikis, Georgios
    Roeder, Falk
    Geier, Michael
    Eckert, Franziska
    Guckenberger, Matthias
    BJU INTERNATIONAL, 2021, 127 (06) : 703 - 711
12345